Rexahn Pharmaceuticals Reports Enrollment Progress on Phase IIb Clinical Trial of Serdaxin for Depression May 5, 2011
Rexahn Pharmaceuticals to Present at Needham & Company's 10th Annual Healthcare Conference Apr 4, 2011
Rexahn Pharmaceuticals to Present Data on Novel Anti-Cancer Small Molecule RX-5902 at AACR 102nd Annual Meeting Mar 30, 2011
Rexahn Pharmaceuticals Enrolls 100 Patients in Serdaxin(R) Phase IIb Clinical Trial for Depression Mar 23, 2011
Rexahn Pharmaceuticals to Present at the Roth Capital Partners 23rd Annual OC Growth Stock Conference Mar 14, 2011
Rexahn Pharmaceuticals Granted European Patent for New Quinoxalinyl-piperazine Compounds Feb 28, 2011